文章：

采用浮动套管与反相技术设计的偶极天线微波消融系统在立体定向经皮肝肿瘤消融中的疗效与安全性：一项前瞻性研究结果

The Efficacy and Safety of a Microwave Ablation System with a Dipole Antenna Design Featuring Floating Sleeves and Anti-Phase Technology in Stereotactic Percutaneous Liver Tumor Ablation: Results from a Prospective Study

原文发布日期：18 December 2024

DOI: 10.3390/cancers16244211

类型: Article

开放获取: 是

英文摘要：

Purpose: To evaluate the efficacy and safety of the Surgnova Dophi™ M150E microwave ablation system in a prospective single-center observational study.Methods: A cohort of 50 patients with 77 primary or secondary liver tumors underwent CT-navigated stereotactic percutaneous microwave ablation with curative intention using the Surgnova Dophi™ M150E system. The endpoints were primary technique efficacy (PTE), number of complications, ablation defect dimensions, and sphericity index compared to previously reported findings.Results: The PTE was 97.4%, with complete ablation in 75 out of 77 tumors. Complications occurred in 10% of patients, with 4% classified as major. A comparison with previous in vivo data confirmed the reliability of the system in achieving reproducible and predictable ablation results.Conclusions: Stereotactic percutaneous microwave ablation with the Surgnova Dophi™ M150E system is safe and effective for liver tumor treatment.

摘要翻译： 

目的：通过前瞻性单中心观察性研究评估Surgnova Dophi™ M150E微波消融系统的有效性与安全性。 方法：采用Surgnova Dophi™ M150E系统，对50例共77个原发性或继发性肝肿瘤患者实施CT导航立体定向经皮微波消融治疗。研究终点包括主要技术有效率（PTE）、并发症发生率、消融灶尺寸及球形度指数，并与既往文献报道结果进行比较。 结果：主要技术有效率为97.4%（77个肿瘤中75个实现完全消融）。并发症发生率为10%，其中严重并发症占4%。与既往体内研究数据对比，证实该系统可获得稳定且可预测的消融效果。 结论：采用Surgnova Dophi™ M150E系统进行立体定向经皮微波消融治疗肝肿瘤安全有效。

原文链接：

The Efficacy and Safety of a Microwave Ablation System with a Dipole Antenna Design Featuring Floating Sleeves and Anti-Phase Technology in Stereotactic Percutaneous Liver Tumor Ablation: Results from a Prospective Study